𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in the diagnosis and management of bladder cancer: Flow cytometry, intravesical bacillus calmette-guerin, and systemic chemotherapy

✍ Scribed by Robert A. Badalament; Joseph R. Drago

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
630 KB
Volume
42
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Recent advances in the diagnosis and treatment of patients with bladder cancer include flow cytometry , intravesical bacillus Calmette-Guerin (BCG), and systemic chemotherapy. Once the subjects of clinical research protocols, these modalities are currently being incorporated into the general management of patients with bladder cancer. Flow cytometry , intravesical BCG, and systemic chemotherapy will be individually reviewed and their role in the management of patients with bladder cancer will be discussed.

📜 SIMILAR VOLUMES

Monitoring intravesical bacillus Calmett
Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by serial flow cytometry
✍ Robert A. Badalament; Helen Gay; Willet F. Whitmore Jr.; Harry W. Herr; William 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Simultaneous urinary flow cytometry, cytologic, and cystoscopic examinations were performed at 3-month intervals for a minimum of 1 year on 29 patients receiving intravesical bacillus Calmette-Guerin (BCG) treatment of superficial bladder carcinoma. Flow cytometry (FCM) and cytology were concordant

Intravesical 4′-epi-doxorubicin(epirubic
Intravesical 4′-epi-doxorubicin(epirubicin) versus bacillus calmette—guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer
✍ Michael D. Melekos; Heracles S. Chionis; George S. Paranychianakis; Houssam H. D 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

Background. The selection of the most appropriate antineoplastic agent and optimal treatment schedule for the prophylaxis of superficial bladder cancer against tumor recurrences is the subject of continual investigations. Methods. A controlled prospective trial involving 161 patients evaluated and

The prognostic value of cytology and flu
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
✍ Spasenija Savic; Inti Zlobec; George N. Thalmann; Daniel Engeler; Martina Schmau 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 169 KB

## Abstract Molecular markers reliably predicting failure or success of Bacillus Calmette‐Guérin (BCG) in the treatment of nonmuscle‐invasive urothelial bladder cancer (NMIBC) are lacking. The aim of our study was to evaluate the value of cytology and chromosomal aberrations detected by fluorescenc